Trunk muscle dysfunction in patients with myotonic dystrophy type 2 and its contribution to chronic low back pain
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F23%3A00078502" target="_blank" >RIV/65269705:_____/23:00078502 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/23:00132387
Result on the web
<a href="https://www.frontiersin.org/articles/10.3389/fneur.2023.1258342/full" target="_blank" >https://www.frontiersin.org/articles/10.3389/fneur.2023.1258342/full</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3389/fneur.2023.1258342" target="_blank" >10.3389/fneur.2023.1258342</a>
Alternative languages
Result language
angličtina
Original language name
Trunk muscle dysfunction in patients with myotonic dystrophy type 2 and its contribution to chronic low back pain
Original language description
IntroductionMyotonic dystrophy type 2 (MD2) presents with a varied manifestation. Even though the myopathy in these patients is more widespread, axial musculature involvement is one of the most prominent conditions. MD2 patients also often report chronic low back pain (CLBP). The purpose of this study was to evaluate trunk muscle function, including respiratory muscles, in patients with MD2 and to compare it with healthy controls, to determine the occurrence of CLBP in patients with MD2, and to assess whether trunk muscle dysfunction increases the risk of CLBP in these patients.MethodsWe enrolled 40 MD2 patients (age range 23 to 76 years, 26 women). A comprehensive battery of tests was used to evaluate trunk muscle function. The tests consisted of quantitative muscle strength testing of low back extensor muscles and respiratory muscles and the assessment of trunk muscle endurance. A neurological evaluation contained procedures assessing the distribution of muscle weakness, myotonia, and pain, and used questionnaires focused on these items and on disability, depression, and physical activity.ResultsThe results of this study suggest that patients with MD2 show significant dysfunction of the trunk muscles, including the respiratory muscles, expressed by decreased muscle strength and endurance. The prevalence of CLBP in patients with MD2 was 52.5%. Based on our analysis, the only independent significant risk factor for CLBP in these patients was maximal isometric lower back extensor strength in a prone position <= 15.8 kg (OR = 37.3). Other possible risk factors were severity of myotonia and reduced physical activity.ConclusionOutcomes of this study highlighted the presence of axial muscle dysfunction, respiratory muscle weakness, and frequent occurrence of CLBP together with its risk factors in patients with MD2. We believe that the findings of this study may help in management and prevention programs for patients with MD2.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30210 - Clinical neurology
Result continuities
Project
<a href="/en/project/EF19_073%2F0016943" target="_blank" >EF19_073/0016943: Internal grant agency of Masaryk University</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Frontiers in Neurology
ISSN
1664-2295
e-ISSN
1664-2295
Volume of the periodical
14
Issue of the periodical within the volume
OCT 2023
Country of publishing house
CH - SWITZERLAND
Number of pages
13
Pages from-to
1258342
UT code for WoS article
001099114100001
EID of the result in the Scopus database
2-s2.0-85176296876